Authors: SEROR V COSTET N

Citation: V. Seror et N. Costet, DOWN-SYNDROME SERUM MARKER SCREENING - DECISION CRITERIA AND IMPLICITVALUES, Health policy, 43(1), 1998, pp. 83-96

Authors: SEROR V COSTET N LEGALES C AYME S

Citation: V. Seror et al., ECONOMIC-ANALYSIS OF MATERNAL SERUM MARKERS SCREENING FOR DOWN-SYNDROME, American journal of human genetics, 61(4), 1997, pp. 307-307

Authors: JOLIOT E VANLEMMENS C KERLEAU M LEGALES C WORONOFFLEMSI MC FLORI YA SEROR V HRUSOVSKY S MONNET E BRESSONHADNI S MIGUET JP

Citation: E. Joliot et al., COST-EFFECTIVENESS STUDY OF TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS-C, Gastroenterologie clinique et biologique, 20(11), 1996, pp. 958-967

Authors: SEROR V LEGALES C COURPOTIN C

Citation: V. Seror et al., MEDICAL-CARE COSTS OF CHILDREN BORN TO HI V-INFECTED WOMEN - A PROSPECTIVE-STUDY, Archives de pediatrie, 2(10), 1995, pp. 957-964

Authors: SEROR V MULLER F MOATTI JP LEGALES C BOUE A

Citation: V. Seror et al., ECONOMIC-ASSESSMENT OF MATERNAL SERUM SCREENING FOR DOWNS-SYNDROME USING HUMAN CHORIONIC-GONADOTROPIN, Prenatal diagnosis, 13(4), 1993, pp. 281-292